Binding of 14C‐furazolidone metabolites to the muscular and hepatic proteins of trout

Food Additives and Contaminants

Volumn 13, Issue 2, 1996, Pages 199-209

  Law, F C P ^a   Meng, J ^a,b  

^a SIMON FRASER UNIVERSITY   (Canada)

^b UNIVERSITY OF WYOMING   (United States)

Author keywords

Covalent binding; Furazolidone metabolites; Trout

Indexed keywords

ANTIINFECTIVE AGENT; CARBON; DRUG RESIDUE; FURAZOLIDONE; CARBON 14; LIVER PROTEIN; MUSCLE PROTEIN;

ANIMAL; ANIMAL DISEASE; ARTICLE; BINDING COMPETITION; FOOD CONTAMINATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYDROLYSIS; INTRAVENOUS DRUG ADMINISTRATION; ISOTOPE LABELING; LIVER; METABOLISM; MUSCLE; ORAL DRUG ADMINISTRATION; PROTEIN BINDING; RAINBOW TROUT; ULTRAVIOLET SPECTROPHOTOMETRY; ANIMAL TISSUE; CONTROLLED STUDY; METABOLITE; NONHUMAN; PRIORITY JOURNAL; RESIDUE ANALYSIS; TISSUE LEVEL; WATER TEMPERATURE;

ADMINISTRATION, ORAL; ANIMALS; ANTI-INFECTIVE AGENTS; BINDING, COMPETITIVE; CARBON RADIOISOTOPES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG RESIDUES; FOOD CONTAMINATION; FURAZOLIDONE; HYDROLYSIS; INJECTIONS, INTRAVENOUS; ISOTOPE LABELING; LIVER; MUSCLES; ONCORHYNCHUS MYKISS; PROTEIN BINDING; SPECTROPHOTOMETRY, ULTRAVIOLET;

EID: 0029658918     PISSN: 0265203X     EISSN: 14645122     Source Type: Journal    
DOI: 10.1080/02652039609374398     Document Type: Article

References (21)

1. Abraham, R. T, Knapp, J. E., Minnigh, M. M., Wong, L. K., Zemotis, M. A., and Alvin, J. D., 1984, Reductive metabolism of furazolidone by E. coli and rat liver in vitro. Drug Metabolism and Disposition, 12, 732-741.
2. Anon, A, 1983, Furazolidone. IARC Monographs on the Evaluation of the Carcinogenic Risks of Chemicals to Humans, No. 31 (Lyon: International Agency for Research on Cancer), pp. 141-152.
3. Chamberlain, R. E., 1976, Chemotherapeutic properties of prominent nitrofurans. Journal of Antimicrobials and Chemotherapeutants, 2, 325-336.
4. FDA (Food and Drug Administration), 1991, Nitrofurans; Withdrawal of approval of new animal drug applications; final rule; final decision following a formal evidentiary public hearing. Federal Register, 56, No. 164, 41902-41912.
5. Hoogenboom, L. A. P., van Kammen, M., Berghmans, M. C. J., Koeman, J. H., and Kuiper, H. A., 1991, The use of pig hepatocytes to study the nature of protein-bound metabolites of furazolidone: a new analytical method for their detection. Food and Chemical Toxicology, 29, 321-328.
6. Hunder, G., Schmid, A., and Marying, L., 1987, Investigation on the metabolic degradation of the side chain on furazolidone. Archives of Toxicology, 61, 161-164.
7. 3H]-benzo(a)pyrene in an in situ intestinal preparation in induced and uninduced catfish. Toxicologist, 14, 431.
8. 14C-FZ) in trout following oral administration of medicated feed. Pharmacologist, 34, 181.
9. McCalla, D. R., 1983, Mutagenicity of nitrofuran derivatives: review. Environmental Mutagenesis, 5, 745-765.
10. Nakabeppu, H., and Tatsumi, K., 1984, Metabolism of furazolidone in eels. Chemical and Pharmaceutical Bulletin (Tokyo), 32, 4193-4195.
11. Pal, A. K., and Chatterjee, S. N., 1985, Induction of prophages by furazolidone (MTR 946). Genetic and Toxicology Testing, 156, 69-76.
12. Plakas, S. M., El Said, K. R., and Stehly, G. R., 1994, Furazolidone disposition after intravascular and oral dosing in the channel catfish. Xenobiotica, 24, 1095-1105.
13. Tatsumi, K., Nakabeppu, H., Takahashi, Y, and Kitamura, S., Metabolism in vivo of furazolidone: evidence for formation of an open-chain carboxylic acid and a-ketoglutaric acid from the nitrofuran in rats. Archives of Biochemistry &Biophysics, 234, 112-116.
14. Tatsumi, K., Yamagichi, T., and Yoshimura, R, 1973, Metabolism of drugs. LXXX. The metabolic fate of nitrofuran derivatives. (3). Studies on enzymes in small intestinal mucosa of rat catalyzing degradation of nitrofuran derivatives. Chemical and Pharmaceutical Bulletin, 21, 622-628.
15. 14C-furazolidone in piglets upon oral administration during 10 days and its interaction with tissue macro-molecules. Food Additives and Contaminants, 3, 331-346.
16. Vroomen, L. H. M., Groten, J. P., van Muiswinkel, K., van Veldhuizen, A., and van Bladeren, P. J., 1987, Identification of a reactive intermediate of furazolidone formed by swine liver microsomes. Chem-Biological Interactions, 64, 167-179.
17. Vroomen, L. H. M., Berghmans, M. C. J., Groten, J. P., Koeman, J. H., and van Bladeren, P. J., 1988, Reversible interaction of a reactive intermediate derived from furazolidone with glutathione and protein. Toxicology and Applied Pharmacology, 95, 53-60.
18. Vroomen, L. H. M., Berghmans, M. C. J., van Bladeren, P. J., Groten, J. P., Wissink, C. J., and Kuiper, H. A., 1990, In vivo and in vitro metabolic studies of furazolidone: a risk evaluation. Drug Metabolism Review, 22(6-8), 663-676.
19. Wolwer-Rieck, U., and Buning-Pfaue, H., 1990, The residue behaviour of the furazolidone metabolite 3-(4-cyano-2-oxobutylideneamino)-2-oxazolidone in trout. Zeitschrift fur Lebensmittel-Untersuchung und- Forschung, 191, 319-321.
20. Winterlin, W., Mourer, C. H., Hall, G., Kratzer, M. F., Weaver, G. L. H., Hubble, L. F., and Kim, S. M., 1984, Furazolidone residues in chicken and swine tissues after feeding trials. Journal of Environmental Science and Health, B19, 209-224.
21. Zar, J. H., 1974, Biostatistical Analysis (New Jersey: Prentice-Hall).